Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Titel:
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Auteur:
Dutton, Susan J Ferry, David R Blazeby, Jane M Abbas, Haider Dahle-Smith, Asa Mansoor, Wasat Thompson, Joyce Harrison, Mark Chatterjee, Anirban Falk, Stephen Garcia-Alonso, Angel Fyfe, David W Hubner, Richard A Gamble, Tina Peachey, Lynnda Davoudianfar, Mina Pearson, Sarah R Julier, Patrick Jankowski, Janusz Kerr, Rachel Petty, Russell D